Englander Institute for Precision Medicine
Found 855 results
Author Title Type [ Year(Asc)]
Filters: Corrigendum-whole-genome-and-transcriptome-analysis-pancreatic-acinar-cell-carcinoma is   [Clear All Filters]
2021
Elemento O.  2021.  Towards artificial intelligence-driven pathology assessment for hematological malignancies.. Blood Cancer Discov. 2(3):195-197.
Humeau J, Le Naour J, Galluzzi L, Kroemer G, Pol JG.  2021.  Trial watch: intratumoral immunotherapy.. Oncoimmunology. 10(1):1984677.
Liu D, Augello MA, Grbesa I, Prandi D, Liu Y, Shoag JE, R Karnes J, Trock BJ, Klein EA, Den RB et al..  2021.  Tumor subtype defines distinct pathways of molecular and clinical progression in primary prostate cancer.. J Clin Invest. 131(10)
Galassi C, Vitale I, Galluzzi L.  2021.  Using epigenetic modifiers to target cancer stem cell immunoevasion.. Cancer Cell. 39(12):1573-1575.
Zoughbi WAl, Fox J, Beg S, Papp E, Hissong E, Ohara K, Keefer L, Sigouros M, Kane T, Bockelman D et al..  2021.  Validation of a Circulating Tumor DNA-Based Next-Generation Sequencing Assay in a Cohort of Patients with Solid tumors: A Proposed Solution for Decentralized Plasma Testing.. Oncologist. 26(11):e1971-e1981.
Carrot-Zhang J, Yao X, Devarakonda S, Deshpande A, Damrauer JS, Silva TChedraoui, Wong CK, Choi HYoung, Felau I, A Robertson G et al..  2021.  Whole-genome characterization of lung adenocarcinomas lacking the RTK/RAS/RAF pathway.. Cell Rep. 34(5):108707.
2020
Casiraghi N, Orlando F, Ciani Y, Xiang J, Sboner A, Elemento O, Attard G, Beltran H, Demichelis F, Romanel A.  2020.  ABEMUS: platform-specific and data-informed detection of somatic SNVs in cfDNA.. Bioinformatics. 36(9):2665-2674.
Palikuqi B, Nguyen D-HT, Li G, Schreiner R, Pellegata AF, Liu Y, Redmond D, Geng F, Lin Y, Gómez-Salinero JM et al..  2020.  Adaptable haemodynamic endothelial cells for organogenesis and tumorigenesis.. Nature. 585(7825):426-432.
Ginter PS, McIntire PJ, Kurtis B, Mirabelli S, Motanagh S, Hoda S, Elemento O, Shin SJ, Mosquera JMiguel.  2020.  Adenomyoepithelial tumors of the breast: molecular underpinnings of a rare entity.. Mod Pathol. 33(9):1764-1772.
Ge Y, Miao Y, Gur-Cohen S, Gomez N, Yang H, Nikolova M, Polak L, Hu Y, Verma A, Elemento O et al..  2020.  The aging skin microenvironment dictates stem cell behavior.. Proc Natl Acad Sci U S A. 117(10):5339-5350.
Antonarakis ES, Velho PIsaacsson, Fu W, Wang H, Agarwal N, Santos VSacristan, Maughan BL, Pili R, Adra N, Sternberg CN et al..  2020.  -Altered Prostate Cancer: Clinical Features and Therapeutic Outcomes to Standard Systemic Therapies, Poly (ADP-Ribose) Polymerase Inhibitors, and PD-1 Inhibitors.. JCO Precis Oncol. 4:370-381.
Rheinbay E, Nielsen MMuhlig, Abascal F, Wala JA, Shapira O, Tiao G, Hornshøj H, Hess JM, Juul RIstrup, Lin Z et al..  2020.  Analyses of non-coding somatic drivers in 2,658 cancer whole genomes.. Nature. 578(7793):102-111.
Armstrong AJ, Al-Adhami M, Lin P, Parli T, Sugg J, Steinberg J, Tombal B, Sternberg CN, de Bono J, Scher HI et al..  2020.  Association Between New Unconfirmed Bone Lesions and Outcomes in Men With Metastatic Castration-Resistant Prostate Cancer Treated With Enzalutamide: Secondary Analysis of the PREVAIL and AFFIRM Randomized Clinical Trials.. JAMA Oncol. 6(2):217-225.
Otto L, Budde K, Kastenmüller G, Kaul A, Völker U, Völzke H, Adamski J, Kühn JP, Krumsiek J, Artati A et al..  2020.  Associations between adipose tissue volume and small molecules in plasma and urine among asymptomatic subjects from the general population.. Sci Rep. 10(1):1487.
Adams EJ, Karthaus WR, Hoover E, Liu D, Gruet A, Zhang Z, Cho H, DiLoreto R, Chhangawala S, Liu Y et al..  2020.  Author Correction: FOXA1 mutations alter pioneering activity, differentiation and prostate cancer phenotypes.. Nature. 585(7826):E20.
Marchi S, Giorgi C, Galluzzi L, Pinton P.  2020.  Ca Fluxes and Cancer.. Mol Cell. 78(6):1055-1069.
Truxova I, Kasikova L, Salek C, Hensler M, Lysak D, Holicek P, Bilkova P, Holubova M, Chen X, Mikyskova R et al..  2020.  Calreticulin exposure on malignant blasts correlates with improved natural killer cell-mediated cytotoxicity in acute myeloid leukemia patients.. Haematologica. 105(7):1868-1878.
Punjani N, Lamb DJ.  2020.  Canary in the Coal Mine? Male Infertility as a Marker of Overall Health. Annu Rev Genet. 54:465-486.
Petroni G, Galluzzi L.  2020.  Cancer Immunotherapy with CDK7 Inhibitors.. Trends Cancer. 6(5):361-363.
Petroni G, Vitale I, Galluzzi L.  2020.  Caspase 2 and p53 Reunited in Tumor Control.. Trends Cell Biol. 30(12):917-918.
Hwang I, Pan H, Yao J, Elemento O, Zheng H, Paik J.  2020.  CIC is a critical regulator of neuronal differentiation.. JCI Insight. 5(9)
Beltran H, Romanel A, Conteduca V, Casiraghi N, Sigouros M, Franceschini GMarco, Orlando F, Fedrizzi T, Ku S-Y, Dann E et al..  2020.  Circulating tumor DNA profile recognizes transformation to castration-resistant neuroendocrine prostate cancer.. J Clin Invest. 130(4):1653-1668.
Iacono A, Pompa A, De Marchis F, Panfili E, Greco FA, Coletti A, Orabona C, Volpi C, Belladonna ML, Mondanelli G et al..  2020.  Class IA PI3Ks regulate subcellular and functional dynamics of IDO1.. EMBO Rep. 21(12):e49756.
Kolin DA, Kulm S, Elemento O.  2020.  Clinical and Genetic Characteristics of Covid-19 Patients from UK Biobank.. medRxiv.
Kolin DA, Kulm S, Christos PJ, Elemento O.  2020.  Clinical, regional, and genetic characteristics of Covid-19 patients from UK Biobank.. PLoS One. 15(11):e0241264.